Livagen 20 mg

Livagen is a short-chain peptide bioregulator composed of the tetrapeptide sequence Lys-Glu-Asp-Ala (KEDA). It is primarily studied for its role in gene expression regulation, protein synthesis, antioxidant balance, and cellular aging mechanisms, with a particular focus on liver-associated biological pathways.

Livagen is widely investigated in experimental models related to hepatic protection, immune modulation, oxidative stress regulation, and age-associated cellular changes. Its biological activity is linked to modulation of enzyme activity and chromatin structure, making it relevant for research into systemic regulation rather than isolated molecular effects.

(Timofeeva et al., 2005 — Bulletin of Experimental Biology and Medicine).

The peptide is supplied as a lyophilized powder to ensure optimal stability during storage and handling.

Livagen (KEDA Tetrapeptide)

Livagen is studied as a peptide bioregulator capable of influencing gene transcription and protein synthesis through interactions with chromatin and regulatory enzymes. Research indicates that Livagen can activate chromatin regions in aging cells, supporting investigation into epigenetic regulation and age-related gene silencing reversal.

Liver and Metabolic Regulation Research

In hepatic research models, Livagen is commonly examined for:

Modulation of liver enzyme activity

Support of antioxidant balance

Restoration of immune and metabolic parameters in liver-associated stress models

Scientific literature frequently discusses Livagen in the context of hepatoprotective peptide systems, especially in experimental models of acute and chronic liver stress.

Enzyme Activity and Opioid System Studies

Livagen has been studied for its interaction with digestive enzymes and enkephalin-degrading enzymes in serum. Experimental findings suggest:

Regulation of digestive enzyme activity in age-dependent models

Inhibition of enkephalin-degrading enzymes without direct opioid receptor binding

These properties make Livagen relevant to research into enzyme regulation, neuroendocrine balance, and systemic peptide signaling.

Cellular Aging and Chromatin Activation Models

A key area of Livagen research involves its effects on chromatin structure and ribosomal gene activity, particularly in aging lymphocytes. Studies have explored:

Activation of ribosomal genes

Decondensation of heterochromatin regions

Restoration of age-suppressed gene expression

This positions Livagen as a tool for investigating epigenetic aging mechanisms and cellular rejuvenation pathways.

Conclusion

Livagen is a peptide bioregulator formulated to support advanced research into liver-associated biological regulation, enzyme modulation, chromatin activation, and cellular aging mechanisms. By influencing gene expression, antioxidant balance, and enzyme activity, it enables investigation of system-level regulatory processes rather than single-target effects.

Its formulation is suited for exploratory research focused on aging biology, hepatic protection models, immune regulation, and epigenetic control pathways.